Phase 2 open-label study of amonafide L-malate in combination with cytarabine in subjects with secondary acute myeloid leukemia (AML)
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2010
At a glance
- Drugs Amonafide; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Antisoma
- 05 Jun 2010 Results presented at the ASCO 2010, according to a Antisoma media release.
- 07 Dec 2009 Final results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH 2009), according to a Antisoma media release.
- 09 Dec 2008 Updated results were presented at the 50th Annual Meeting of the American Society of Hematology.